Instil Bio, Inc. Retained Earnings
Instil Bio, Inc. (TIL) had Retained Earnings of -$734.99 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$734.99M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$730.69M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$726.49M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$718.30M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$734.99M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$730.69M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$726.49M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$718.30M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$704.71M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$683.32M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$655.12M 10-K · filed 2026-03-27 |
| 2024-09-30 | -$643.22M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$620.20M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$605.28M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$580.98M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$568.06M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$500.62M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$481.96M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$424.89M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$371.05M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$314.83M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$255.83M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$201.72M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$146.37M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$103.36M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$68.05M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$44.92M 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |